Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of Diclofenac Diethylamine Gel in Knee OA
NCT03497039Phase 1Completed
- Sponsor
- GSK
- Start
- Jul 2018
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 1, randomised, double-blind trial of diclofenac diethylammonium in osteoarthritis (OA) (2 arms), sponsored by GSK. Primary endpoints: Diclofenac Concentration in Treated Knee Synovial Tissue at Day 8 and Diclofenac Concentration in Treated Knee Synovial Fluid at Day 8. Started Jul 2018; status: completed.
02
Drugs
diclofenac diethylammonium
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT03497039.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03497039.